Scarica l'app Stockscreener
0.6958
3.44%
-0.0248
Dopo l'orario di chiusura:
.71
0.0142
+2.04%
Imunon Inc Borsa (IMNN) Ultime notizie
FY2024 EPS Estimates for Imunon Boosted by Zacks Small Cap - Defense World
Analysts Set Expectations for Imunon Q1 Earnings - Defense World
Imunon, Inc. (NASDAQ:IMNN) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Imunon reveals promising ovarian cancer study results - Investing.com India
Earnings call: Imunon reveals promising ovarian cancer study results By Investing.com - Investing.com UK
Imunon Inc (IMNN) Q3 2024 Earnings Call Highlights: Promising Clinical Advances Amid Financial ... - Yahoo Finance
Imunon, Inc. Reports Q3 2024 Earnings and Progress - TipRanks
Imunon Inc (IMNN) Quarterly 10-Q Report - Quartzy
Imunon presents data from Phase 2 OVATION 2 clinical trial - TipRanks
IMUNON Presents Positive Data from Phase 2 OVATION 2 - GlobeNewswire
IMUNON's Cancer Drug Shows 35% Survival Boost in Phase 2 Ovarian Cancer Trial | IMNN Stock News - StockTitan
Imunon sees cash runway into 3Q25 - TipRanks
IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
IMUNON INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Imunon (IMNN) to Release Quarterly Earnings on Thursday - MarketBeat
IMUNON to Hold Third Quarter 2024 Financial Results and - GlobeNewswire
IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024 - Yahoo Finance
IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of - GlobeNewswire
IMUNON, Inc. to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting - Marketscreener.com
Imunon’s stock rockets after ovarian cancer treatment’s positive trial results - MSN
Imunon reports inducement grant under NASDAQ listing rule - Yahoo Finance
Ex-Allstate Atty Named Biotech Co.'s General Counsel - Law360
Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team - TipRanks
IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Imunon, Inc. Appoints Susan Eylward as General Counsel and Corporate Secretary - Marketscreener.com
Imunon (NASDAQ:IMNN) Upgraded by EF Hutton Acquisition Co. I to “Strong-Buy” - Defense World
Imunon (NASDAQ:IMNN) Upgraded to "Strong-Buy" at EF Hutton Acquisition Co. I - MarketBeat
EF Hutton sets stock target on Imunon, initiates with buy rating - Investing.com Canada
Ratio Review: Analyzing Imunon Inc (IMNN)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Imunon Inc (IMNN) may enjoy gains as insiders got busy in the recent days - Knox Daily
Imunon (NASDAQ:IMNN) Stock, Analyst Ratings, Price Targets, Forecasts - Benzinga
You might want to take a look at Imunon Inc (IMNN) now - SETE News
A review of IMNN’s current quarter earnings predictions - US Post News
Imunon (NASDAQ:IMNN) Shares Up 5.6% - Defense World
IMNN (Imunon Inc) may reap gains as insiders became active recently - Knox Daily
UPDATEIMUNON’s Ovarian Cancer R&D Day to Feature - GlobeNewswire
IMNNImunon, Inc. Latest Stock News & Market Updates - StockTitan
IMUNON’s Ovarian Cancer R&D Day to Feature Presentations - GlobeNewswire
IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management - StockTitan
Imunon Inc. resumes ATM equity offering - Investing.com
Ratios Uncovered: Breaking Down Imunon Inc (IMNN)’s Trailing Twelve Months Metrics - The Dwinnex
Imunon Inc’s latest rating changes from various analysts - Knox Daily
The Attractiveness of Investing In Imunon Inc (IMNN) is Growing - Knox Daily
IMUNON to Host R&D Day on September 18th - GlobeNewswire
A significant driver of top-line growth: Imunon Inc (IMNN) - SETE News
Celsion Corporation : Celsion Announces Official ThermoDox® HEAT Study Results to be presented at the International Liver Cancer Association (ILCA) 2013 Annual Conference in Washington, D.C. on September 14, 2013 - Marketscreener.com
Imunon Inc [IMNN] Investment Guide: What You Need to Know - Knox Daily
Imunon Inc (IMNN) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Market Watch: Imunon Inc (IMNN)’s Noteworthy Gain, Closing at 1.14 - The Dwinnex
Q3 2024 EPS Estimates for Imunon, Inc. (NASDAQ:IMNN) Increased by Analyst - Defense World
Q3 2024 Earnings Estimate for Imunon, Inc. (NASDAQ:IMNN) Issued By Brookline Capital Management - Defense World
Stacy Lindborg Buys 25,000 Shares of Imunon, Inc. (NASDAQ:IMNN) Stock - Defense World
Imunon (NASDAQ:IMNN) Rating Reiterated by HC Wainwright - Defense World
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):